Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia — MASTERKEY ASIA  

Rare Malignant Neoplasm Clinical Trial

Official title: A Prospective Clinical Registry Study of Genetic Profiling and Targeted Therapies in Patients With Rare Cancers in ASIA

Status Recruiting

Clinical Trial Summary

This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing.

The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Neoplasms

• NCT number: NCT05217407
• Study type: Observational [Patient Registry]
• Source: National Cancer Center, Japan
• Contact: Chiharu Mizoguchi, MD
• Phone: +81-(0)3-3542-2511
• Email: ncch2007_office@ml.res.ncc.go.jp
• Status: Recruiting
• Start date: November 30, 2021
• Completion date: March 31, 2030